Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.84 HKD | +4.67% | +3.52% | +35.54% |
05-22 | Henlius Biotech Gets China Approval for New Indications of Arthritis Drug | MT |
05-22 | Henlius Biotech Amends License Deals with Palleon for Bifunctional Protein Products | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+35.54% | 1.31B | |
-2.00% | 90.27B | |
+1.32% | 40.12B | |
-15.73% | 31.75B | |
+62.99% | 26.6B | |
-21.28% | 14.41B | |
-8.50% | 12.92B | |
-44.07% | 11.3B | |
-13.06% | 11.44B | |
+4.57% | 8.87B |
- Stock Market
- Equities
- 2696 Stock
- News Shanghai Henlius Biotech, Inc.
- Henlius Biotech Gets Clearance for China Clinical Trial of Carcinoma Drug